EUVIMED · CrossrefJournal
Journal of Clinical and Experimental Hepatology
ISSN 0973-6883 · Elsevier BV
Latest articles
Portal Vein Thrombosis: The Indian National Association for Study of the Liver Recommendations for Management
Phenotypic Clustering as a Tool for Uncovering Hidden Risk Profiles in End-stage Liver Disease: An Exploratory Analysis of Sarcopenia and 1-Year Mortality
Effectiveness and Safety of Thalidomide for Gastric Antral Vascular Ectasia–Related Recurrent Gastrointestinal Bleed in Liver Cirrhosis: Prospective Observational Study
Plant-based Dietary Patterns and the Risk of Metabolic Dysfunction–Associated Steatotic Liver Disease and Liver Cancer: A Systematic Review and Meta-analysis
Performance of Biochemical Response Criteria for Predicting Hepatic Decompensation in Cirrhotic Patients with Primary Biliary Cholangitis
Component-Resolved Analysis of HBcrAg-Related Assay Signals Across Clinical Phases of Chronic HBV Infection
Reply to Letter to Editor: “Dietary quality, not plant content, in MASLD prevention”
Emerging Role of Histotripsy in the Management of Hepatic Malignancies: A Systematic Review
Pancreatic Exocrine Insufficiency in Indian MASLD: Prevalence and Predictors Versus Health-Check Controls
Expanding The Scope of Endohepatology: A Single Center Experience of Endoscopic Ultrasound guided Locoregional Therapies for Hepatocellular Carcinoma [With Video]
PNPLA3 as a severity modifier and the susceptibility–progression distinction in Indian MASLD: response to Kaushal et al.
Extracorporeal Liver Support techniques in Acute Liver Failure: A Need for Practice Standardization A Multicenter Survey in Canadian and French Liver Transplant Centers
Corrigendum to “Post Hoc Analysis of a Phase 2 Randomized Trial of Pemafibrate in Metabolic Dysfunction–associated Steatotic Liver Disease: Associations With Platelet Count, Liver Stiffness, and Spleen Volume” [J Clin Exp Hepatol 16 (4) (2026) 103525]
Post Hoc Analysis of a Phase 2 Randomized Trial of Pemafibrate in Metabolic Dysfunction–associated Steatotic Liver Disease: Associations With Platelet Count, Liver Stiffness, and Spleen Volume
Self-Reported Cognitive Function in Metabolic Dysfunction–associated Steatotic Liver Disease and Metabolic Dysfunction–associated Steatohepatitis: A Post-hoc Analysis of the MAESTRO Resmetirom Trials
Sex Differences in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Epidemiology, Pathophysiology, and Clinical Implications
Enhancing Clinical Applicability of Laboratory-Based Machine Learning Models for Advanced Fibrosis in MASLD
Magnetic Resonance Elastography Versus Shear Wave Elastography in Chronic Liver Disease
Nor-ursodeoxycholic Acid for Metabolic Dysfunction-associated Steatotic Liver Disease: Is There Enough Evidence for Clinical Use? A Critique of a Phase III Trial and Regulatory Endorsement of the Drug
Delineating Metabolic Dysfunction-Associated Steatotic Liver Disease and Comorbid Risk With Clinical, Blood and Metabolomic Parameters—A UK Biobank Analysis
Relative Adrenal Insufficiency is Associated With Worse Clinical Outcomes in Patients With Acute Decompensation of Cirrhosis and Hyponatremia
Hepatocellular Carcinoma in Non-cirrhotic Portal Fibrosis/Idiopathic Portal Hypertension: An Under-recognized Complication—A Case Report and Literature Review
Adult-Diagnosed Alagille Syndrome Presenting as Isolated Liver Disease
Difficult to Treat Autoimmune Hepatitis: A Pediatric Hepatology Perspective
Prevalence and Impact of Cirrhotic Cardiomyopathy on Adverse Outcomes Following Liver Transplantation: A Systematic Review and a Meta-Analysis
Impact of Acculturation Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Among Mexican Americans
Endo-Hepatology and Artificial Intelligence: New Avenues for Diagnosis and Intervention
Alpha-1 Antitrypsin Deficiency Alleles in Non-Cirrhotic Hepatocellular Carcinoma: Insights from a Multicenter French Cohort
Clinical Determinants of Delayed Diagnosis in Wilson's Disease: Misdiagnosis Patterns, Phenotypes, and Impact on Survival
The Changing Paradigm of Etiology in Acute Liver Failure in India: Hepatitis E to A
EUVIMED